仙灵骨葆胶囊联合鲑鱼降钙素治疗绝经期骨质疏松临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R592

基金项目:


Clinical Study on Xianling Gubao Capsules Combined with Salmon Calcitonin for Postmenopausal Osteoporosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察仙灵骨葆胶囊联合鲑鱼降钙素治疗绝经期骨质疏松的临床疗效。方法:采用随机数字 表法将120 例绝经期骨质疏松患者分为对照组、观察组各60 例。对照组给予鲑鱼降钙素治疗,观察组给予仙 灵骨葆胶囊联合鲑鱼降钙素治疗,2 组均治疗3 个月。比较2 组治疗前后中医证候积分、简易麦吉尔疼痛问 卷(SF-MPQ) 评分、骨代谢指标[甲状旁腺激素(PTH)、骨钙素(BGP)、降钙素(CT)]、正位腰椎L1~ L4、股骨颈、Ward's 三角区骨密度。评估2 组临床疗效及不良反应发生情况。结果:治疗后,观察组总有效率 高于对照组(P<0.05)。2 组治疗后中医证候积分、SF-MPQ 各维度评分及PTH 水平均较治疗前降低(P< 0.05),正位腰椎L1~L4、股骨颈、Ward's 三角区骨密度及BGP、CT 水平升高(P<0.05);观察组治疗后中医 证候积分、SF-MPQ 各维度评分及PTH 水平均低于对照组(P<0.05),正位腰椎L1~L4、股骨颈、Ward's 三角 区骨密度及BGP、CT 水平均高于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P> 0.05)。结论:仙灵骨葆胶囊联合鲑鱼降钙素治疗绝经期骨质疏松疗效确切,能有效改善患者骨代谢及骨密度 水平,缓解疼痛,安全性较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Xianling Gubao Capsules combined with Salmon Calcitonin on postmenopausal osteoporosis. Methods: A total of 120 patients with postmenopausal osteoporosis were divided into the control group and the observation group according to the random number table method, with 60 cases in each group. The control group was given Salmon Calcitonin for treatment, and the observation group was treated with Xianling Gubao Capsules combined with Salmon Calcitonin. Both groups were treated for three months. The traditional Chinese medicine (TCM) syndrome scores,scores of Short Form McGill Pain Questionnaire (SF-MPQ),levels of bone metabolism indexes, including parathyroid hormone (PTH), bone gamma-carboxyglutamate protein (BGP) and calcitonin (CT),and the bone density of anterior position of lumbar spine (L1~L4),femoral neck and Ward's triangle were compared before and after treatment between the two groups; the clinical effects and incidence of adverse reactions in both groups were evaluated. Results:After treatment,the total effective rate in the observation group was higher than that in the control group (P<0.05). After treatment,the TCM syndrome scores, scores of each dimension in SF-MPQ and PTH levels in both groups were decreased when compared with those before treatment (P<0.05), the bone density of anterior position of lumbar spine (L1~L4), femoral neck and Ward's triangle and the levels of BGP and CT were increased (P<0.05); the TCM syndrome score, scores of each dimension in SF-MPQ and PTH level in the observation group were lower than those in the control group (P<0.05),the bone density of anterior position of lumbar spine (L1~L4),femoral neck and Ward's triangle,and the levels of BGP ,and CT were higher than those in the control group (P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups (P>0.05). Conclusion:The therapy of Xianling Gubao Capsules combined with Salmon Calcitonin has a definite curative effect on postmenopausal osteoporosis,which can effectively improve the levels of bone metabolism and bone density, and mitigate pain with good safety.

    参考文献
    相似文献
    引证文献
引用本文

邹宾.仙灵骨葆胶囊联合鲑鱼降钙素治疗绝经期骨质疏松临床研究[J].新中医,2024,56(1):125-129

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-01-16
  • 出版日期: